Peer-reviewedCC BYFrontiers in pharmacology
Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies
4 affiliations
- 1Department of Thyroid and Breast Surgery, Yantai Affiliated Hospital of Shandong Medical and Pharmaceutical University , , ,
- 2Department of Histology and Embryology, School of Basic Medicine, Shandong Medical and Pharmaceutical University , , ,
- 3Department of Rehabilitation Medicine, Hangzhou First Peoples’ Hospital Xiasha Campus, Hangzhou Rehabilitation Hospital , , ,
- 4Department of Diagnostics, Second School of Clinical Medicine, Shandong Medical and Pharmaceutical University , , ,
Related
- Molecular mechanisms for sustaining cancer stem cells characteristics and targeted therapeutic strategies
- Myocardial Ischemia-Reperfusion Injury: Molecular Mechanisms and Innovative Therapeutic Strategies
- Beyond Weight Loss and Glycemic Control: Molecular Mechanisms and Hypothesis-Generating Therapeutic Potential of Incretin-Based Therapies Against Peritoneal Fibrosis in Peritoneal Dialysis.
- Recent advances in Alzheimer’s disease: From molecular mechanisms to therapeutic strategies
- Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer
BibTeX
@article{dong2026lactylation,
title = {{Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies}},
author = {Zhiwei Dong and Feibo Xu and Mei Ye and Lu Wang},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13655389},
note = {CC BY},
}
RIS
TY - JOUR
TI - Lactylation in liver fibrosis: from molecular mechanisms to targeted therapeutic strategies
AU - Zhiwei Dong
AU - Feibo Xu
AU - Mei Ye
AU - Lu Wang
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13655389
SN - 1663-9812
ER -